|
000
| 01314nas##2200289za#4500 |
|---|
| 001 | 9.512094 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20200331212919 |
|---|
| 007 | ta |
|---|
| 008 | 150406c1989||||xxc|| p #||||f| |0eng|d |
|---|
| 022 | |a0847-4397 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 041 | |aeng |
|---|
| 041 | |afre |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH78 |
|---|
| 110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 245 | 10|aPatented Medicine Prices Review Board annual report |
|---|
| 260 | |aOttawa - Ontario : |bPatented Medicine Prices Review Board |
|---|
| 310 | |aAnnual |
|---|
| 362 | 1 |a1989-- |
|---|
| 520 | 3 |aAn independent, quasi-judicial body, Canada’s Patented Medicine Prices Review Board (PMPRB) regulates the prices of prescription and non-prescription patented drugs for human and veterinary use, ensuring that these prices are not excessive. This report includes a review of the PMPRB’s major activities, as well as analyses of the prices of patented medicines and of the price trends of all drugs. It also lists the R&D expenditures reported by patent-holding drug manufacturers. |
|---|
| 690 | 07|aDrugs|2gcpds |
|---|
| 690 | 07|aPrices|2gcpds |
|---|
| 776 | 0#|tAnnual report |w(CaOODSP)9.506080 |
|---|
| 792 | |tConseil d'examen du prix des médicaments brevetés, rapport annuel |w(CaOODSP)9.512095 |
|---|